Soleno Therapeutics
SLNO • NASDAQ
Soleno Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Anish Bhatnagar, with a market cap of $2.7B.
Market Cap$2.7B
Employees42.0
CEOAnish Bhatnagar
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Soleno Therapeutics FAQ
Common questions about Soleno Therapeutics
Soleno Therapeutics is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $93.8M.
Soleno Therapeutics has approximately 42 employees.